Clearside Biomedical Inc.(CLSD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLSD Clearside Biomedical Inc.

交易中 03-31 12:00:49 EDT

0.9450

-0.0050

-0.53%

最高1.00	最低0.9304	成交量5.27万
今开0.9370	昨收0.9500	日振幅7.33%
总市值7,290万	流通市值6,726万	总股本7,714万
成交额4.98万	换手率0.07%	流通股本7,117万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLSD","market":"US","secType":"STK","nameCN":"Clearside Biomedical Inc.","latestPrice":0.945,"timestamp":1743436524088,"preClose":0.95,"halted":0,"volume":52678,"delay":0,"floatShares":71172365,"shares":77143872,"eps":-0.47,"marketStatus":"交易中","change":-0.005,"latestTime":"03-31 12:00:49 EDT","open":0.937,"high":1,"low":0.9304,"amount":49783.9971072,"amplitude":0.073263,"askPrice":0.9527,"askSize":500,"bidPrice":0.93,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.47,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1743451200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1464840000000,"exchange":"NASDAQ","adjPreClose":0.95,"preHourTrading":{"tag":"盘前","latestPrice":0.9202,"preClose":0.95,"latestTime":"09:25 EDT","volume":608,"amount":562.5160672000001,"timestamp":1743427547060},"postHourTrading":{"tag":"盘后","latestPrice":0.988,"preClose":0.95,"latestTime":"17:37 EDT","volume":315,"amount":312.775,"timestamp":1743197864876},"volumeRatio":0.635476,"impliedVol":3.5184,"impliedVolPercentile":0.9761},"requestUrl":"/m/hq/s/CLSD/tweets","defaultTab":"tweets","newsList":[{"id":"2518224063","title":"Clearside Biomedical, Inc.盘中异动 早盘急速下跌6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518224063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518224063?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613510,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Clearside Biomedical, Inc.股票出现波动，股价急速下挫6.01%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1947.17%、396.20%、52.83%，振幅较大的相关个股有Xencor, Inc.、Seer, Inc.、珐博进，振幅分别为99.13%、98.72%、98.49%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213150a26a2496&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213150a26a2496&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2517910021","title":"Clearside Biomedical, Inc.盘中异动 快速上涨6.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517910021?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:40","pubTimestamp":1741185655,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时40分，Clearside Biomedical, Inc.股票出现异动，股价急速上涨6.60%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为413.63%、265.37%、199.17%，振幅较大的相关个股有Aditxt, Inc.、Silexion Therapeutics Corp、Tonix Pharmaceuticals Holding Corp.，振幅分别为23.90%、20.71%、18.91%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224055989d47f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224055989d47f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2517600496","title":"Clearside Biomedical, Inc.盘中异动 下午盘股价大涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517600496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517600496?lang=zh_cn&edition=full","pubTime":"2025-03-05 02:58","pubTimestamp":1741114688,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日02时58分，Clearside Biomedical, Inc.股票出现波动，股价急速拉升5.38%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305025808989bea21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305025808989bea21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2516378766","title":"Clearside Biomedical, Inc.盘中异动 快速拉升5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516378766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516378766?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:45","pubTimestamp":1741013132,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时45分，Clearside Biomedical, Inc.股票出现异动，股价大幅上涨5.27%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224532abe63803&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224532abe63803&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2513815720","title":"Clearside Biomedical, Inc.盘中异动 急速跳水5.26%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513815720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513815720?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:53","pubTimestamp":1740408818,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时53分，Clearside Biomedical, Inc.股票出现波动，股价急速下跌5.26%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Pepgen Inc.、Telix Pharmaceutic、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为135.68%、55.36%、25.06%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225338962e9e68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225338962e9e68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2513118122","title":"Clearside Biomedical, Inc.盘中异动 下午盘大幅下挫5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513118122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513118122?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:16","pubTimestamp":1740165407,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时16分，Clearside Biomedical, Inc.股票出现波动，股价快速下挫5.18%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222031647988e1a0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222031647988e1a0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2511696191","title":"Clearside Biomedical, Inc.盘中异动 股价大涨5.90%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511696191?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:34","pubTimestamp":1739543670,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时34分，Clearside Biomedical, Inc.股票出现波动，股价大幅上涨5.90%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1078.88%、375.16%、345.81%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virpax Pharmaceuticals, Inc.、Theratechnologies Inc.，振幅分别为20.20%、19.73%、18.33%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422343196231bf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422343196231bf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007","VRPX"],"gpt_icon":0},{"id":"2510338127","title":"Clearside Biomedical, Inc.盘中异动 大幅下跌5.68%报1.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510338127","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510338127?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:34","pubTimestamp":1739284483,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时34分，Clearside Biomedical, Inc.股票出现波动，股价急速跳水5.68%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.96%。其相关个股中，Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、In8Bio, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃，换手率分别为2045.65%、540.02%、179.37%，振幅较大的相关个股有In8Bio, Inc.、Ocean Biomedical, Inc.、知临集团，振幅分别为25.06%、22.23%、16.57%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223443abcb06e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223443abcb06e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4139","OCEA","BK4007"],"gpt_icon":0},{"id":"2510586347","title":"Clearside Biomedical, Inc.盘中异动 早盘股价大跌5.31%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510586347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510586347?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:30","pubTimestamp":1739197830,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时30分，Clearside Biomedical, Inc.股票出现波动，股价快速下跌5.31%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为1449.76%、833.04%、546.47%，振幅较大的相关个股有Solid Biosciences Inc.、Aditxt, Inc.、Impact Biomedical, Inc.，振幅分别为26.04%、6.44%、4.82%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223030abc9a476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223030abc9a476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2509773523","title":"Clearside Biomedical, Inc.盘中异动 下午盘股价大涨5.61%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509773523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509773523?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:03","pubTimestamp":1738955033,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时03分，Clearside Biomedical, Inc.股票出现异动，股价急速拉升5.61%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208030354961b65ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208030354961b65ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2509232950","title":"Clearside Biomedical, Inc.盘中异动 快速拉升5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509232950","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509232950?lang=zh_cn&edition=full","pubTime":"2025-02-06 02:03","pubTimestamp":1738778623,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日02时03分，Clearside Biomedical, Inc.股票出现异动，股价急速拉升5.27%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为2.04%。其相关个股中，Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4543.14%、2237.35%、1686.49%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为122.81%、99.51%、59.58%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206020344987b9dfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206020344987b9dfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","BK4139","BK4007","CLSD"],"gpt_icon":0},{"id":"2505770076","title":"Clearside Biomedical, Inc.盘中异动 下午盘急速上涨5.19%报0.970美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505770076","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505770076?lang=zh_cn&edition=full","pubTime":"2025-01-23 03:51","pubTimestamp":1737575514,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日03时51分，Clearside Biomedical, Inc.股票出现波动，股价快速拉升5.19%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123035154986fa82c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123035154986fa82c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2503539517","title":"Clearside Biomedical, Inc.盘中异动 下午盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503539517","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503539517?lang=zh_cn&edition=full","pubTime":"2025-01-14 02:05","pubTimestamp":1736791535,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日02时05分，Clearside Biomedical, Inc.股票出现异动，股价快速下挫5.10%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为13061.49%、7412.21%、682.47%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、221.73%、201.86%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114020535a22073b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114020535a22073b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAIR","CLSD","BK4007","BK4139","KAPA"],"gpt_icon":0},{"id":"2500477756","title":"Clearside Biomedical, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500477756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500477756?lang=zh_cn&edition=full","pubTime":"2025-01-01 04:42","pubTimestamp":1735677746,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日04时42分，Clearside Biomedical, Inc.股票出现波动，股价快速下跌5.01%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501010442269856db3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501010442269856db3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2495529766","title":"Clearside Biomedical, Inc.盘中异动 早盘大幅拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495529766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495529766?lang=zh_cn&edition=full","pubTime":"2024-12-30 23:24","pubTimestamp":1735572276,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日23时24分，Clearside Biomedical, Inc.股票出现波动，股价大幅上涨5.15%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为1.10%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230232436ab983301&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230232436ab983301&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2494869456","title":"Clearside Biomedical, Inc.盘中异动 大幅下挫5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494869456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494869456?lang=zh_cn&edition=full","pubTime":"2024-12-26 22:56","pubTimestamp":1735224994,"startTime":"0","endTime":"0","summary":"北京时间2024年12月26日22时56分，Clearside Biomedical, Inc.股票出现波动，股价大幅下挫5.27%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226225634a20a99f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226225634a20a99f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2494329470","title":"Clearside Biomedical, Inc.盘中异动 快速拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494329470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494329470?lang=zh_cn&edition=full","pubTime":"2024-12-25 01:44","pubTimestamp":1735062291,"startTime":"0","endTime":"0","summary":"北京时间2024年12月25日01时44分，Clearside Biomedical, Inc.股票出现异动，股价大幅上涨5.23%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225014451ab90e264&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225014451ab90e264&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2492344428","title":"Clearside Biomedical, Inc.盘中异动 股价大跌12.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492344428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492344428?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:35","pubTimestamp":1734705307,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时35分，Clearside Biomedical, Inc.股票出现波动，股价快速跳水12.60%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Humacyte, Inc.、Humacyte Inc C/Wts 27/08/2026 、Psyence Biomedical Ltd.涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为1769.12%、80.09%、55.09%，振幅较大的相关个股有Humacyte, Inc.、Quoin Pharmaceuticals Ltd、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为33.53%、30.92%、29.60%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223507ab876694&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223507ab876694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2489614421","title":"Clearside Biomedical, Inc.盘中异动 大幅下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489614421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2489614421?lang=zh_cn&edition=full","pubTime":"2024-12-05 04:41","pubTimestamp":1733344890,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日04时41分，Clearside Biomedical, Inc.股票出现异动，股价大幅下挫5.09%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205044130971baf8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205044130971baf8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2485294532","title":"Clearside Biomedical, Inc.盘中异动 大幅拉升5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485294532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2485294532?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:41","pubTimestamp":1732297278,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时41分，Clearside Biomedical, Inc.股票出现波动，股价快速上涨5.88%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Replimune Group, Inc.、Exicure, Inc.、Sol-Gel Technologies Ltd.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1855.47%、151.14%、94.19%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Ocean Biomedical Inc C/Wts 14/02/2028 、Virpax Pharmaceuticals, Inc.，振幅分别为81.82%、75.32%、72.75%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123014118971a826e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123014118971a826e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.clearsidebio.com","stockEarnings":[{"period":"1week","weight":-0.0547},{"period":"1month","weight":0.0556},{"period":"3month","weight":0},{"period":"6month","weight":-0.181},{"period":"1year","weight":-0.3791},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0148},{"period":"1month","weight":-0.0654},{"period":"3month","weight":-0.0661},{"period":"6month","weight":-0.0277},{"period":"1year","weight":0.0623},{"period":"ytd","weight":-0.0519}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Clearside Biomedical, Inc.于2011年5月26日在特拉华州注册成立。该公司是一个后期临床生物制药公司，开发先入类药物疗法来治疗眼睛的致盲疾病。公司目前的候选产品着力解决影响视网膜和脉络膜，尤其是黄斑水肿相关的疾病，并注入到使用其专有的SCS微量注射器脉络膜上腔。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.035821},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.036687},{"month":3,"riseRate":0.555556,"avgChangeRate":0.066853},{"month":4,"riseRate":0.5,"avgChangeRate":-0.011671},{"month":5,"riseRate":0.25,"avgChangeRate":-0.080267},{"month":6,"riseRate":0.75,"avgChangeRate":0.163204},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.038074},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.074112},{"month":9,"riseRate":0.444444,"avgChangeRate":0.150007},{"month":10,"riseRate":0.333333,"avgChangeRate":0.04158},{"month":11,"riseRate":0.555556,"avgChangeRate":-0.029261},{"month":12,"riseRate":0.333333,"avgChangeRate":0.048543}],"exchange":"NASDAQ","name":"Clearside Biomedical Inc.","nameEN":"Clearside Biomedical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Clearside Biomedical Inc.(CLSD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Clearside Biomedical Inc.(CLSD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Clearside Biomedical Inc.,CLSD,Clearside Biomedical Inc.股票,Clearside Biomedical Inc.股票老虎,Clearside Biomedical Inc.股票老虎国际,Clearside Biomedical Inc.行情,Clearside Biomedical Inc.股票行情,Clearside Biomedical Inc.股价,Clearside Biomedical Inc.股市,Clearside Biomedical Inc.股票价格,Clearside Biomedical Inc.股票交易,Clearside Biomedical Inc.股票购买,Clearside Biomedical Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Clearside Biomedical Inc.(CLSD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Clearside Biomedical Inc.(CLSD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}